←
Swanton Lab186 posts
Swanton Lab avatar

Swanton Lab

@SwantonLab

The Cancer Evolution and Genome Instability Lab is led by @CharlesSwanton and is based @TheCrick and @uclcancer.

◷ Joined April 2016▧ 28 Photos and videos
Rob Hynds avatar
⟳ Swanton Lab retweeted
Rob Hynds@robhynds·3 Jul 2025

Excited to share our new paper with Sheila's lab: we performed an in vivo genome-wide CRISPRa screen using a lung TRACERx PDX model to uncover drivers of brain metastasis. BACE1 emerged as a key hit - especially interesting given ongoing therapeutic efforts in Alzheimer’s.

New publication! A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis | Science Translational Medicine science.org/doi/10.1126/scit… @ScienceTM

soria avatar
⟳ Swanton Lab retweeted
soria@jsoriamd·25 Apr 2025

CHIP is a common, age-related condition where mutated blood stem cells expand without causing blood disorders. CHIP raises the risk of hematological malignancies, chronic inflammatory diseases (like heart & lung disease), & lung cancer. This manuscript shows that CHIP somatic clones in blood—especially TET2 mutant ones—migrate into tumors, reshape immunity, drive progression, and promote recurrence. The ability of a somatic clonal expansion in the hematopoietic compartment, to regulate malignant progression in another tissue represents a new perspective in cancer biology. #CHIP #LCMS #cancer #biology #AACR25 nejm.org/doi/full/10.1056/NE…

Post attachment
Rob Hynds avatar
⟳ Swanton Lab retweeted
Rob Hynds@robhynds·20 Dec 2024

Great to see this collaborative paper out @NatureComms. @TimWitney's team developed a PET radiotracer that distinguishes high/low NRF2 antioxidant pathway activation, including in our @CRUKLungCentre PDX models. Congrats @hgreenwood93 and team! 👏 nature.com/articles/s41467-0…

Rob Hynds avatar
⟳ Swanton Lab retweeted
Rob Hynds@robhynds·28 Nov 2024

Our TRACERx non-small cell lung cancer (NSCLC) patient-derived-xenograft (PDX) models are now available through CancerTools.org 🎉 A big thank you to Dave Pearce and the incredible @CRUKLungCentre team who have made this possible!

We’re excited to share that our TRACERx NSCLC patient-derived xenograft models are now available to the research community through @CancerToolsOrg 🥳 cancertools.org/nsclc-pdx-mo… [cancertools.org]

Charles Swanton avatar
⟳ Swanton Lab retweeted
Charles Swanton@CharlesSwanton·19 Jul 2024

Today our study of the association between replication timing alterations and mutation acquisition during cancer evolution has been published in @NatureComms nature.com/articles/s41467-0…

Charles Swanton avatar
⟳ Swanton Lab retweeted
Charles Swanton@CharlesSwanton·13 Jun 2024

Why do some patients benefit less than others from precision cancer medicine? We are excited to share our paper "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling” out in @NatureComms. nature.com/articles/s41467-0… 🧵

Charles Swanton avatar
⟳ Swanton Lab retweeted
Charles Swanton@CharlesSwanton·31 May 2024

Patient-derived xenograft (PDX) models allow cancer researchers to study tumour tissue from patients in mice. Our @CRUKLungCentre paper @NatureComms describes 48 new PDX models and highlights the importance of intratumor heterogeneity in the development of cancer models (1/9)

Post attachment
Rob Hynds avatar
⟳ Swanton Lab retweeted
Rob Hynds@robhynds·1 Jun 2024

My @SwantonLab postdoc paper is now out @NatureComms. It was a huge privilege to work with the TRACERx team. Thanks to @AMIHuebner and Dave Pearce, as well as everyone else @uclcancer, @TheCrick and @CRUK_MI who made this happen.

Patient-derived xenograft (PDX) models allow cancer researchers to study tumour tissue from patients in mice. Our @CRUKLungCentre paper @NatureComms describes 48 new PDX models and highlights the importance of intratumor heterogeneity in the development of cancer models (1/9)

Post attachment
Faiz Jabbar avatar
⟳ Swanton Lab retweeted
Faiz Jabbar@faizjab·8 Feb 2024

Extremely grateful and excited to have support from @CRUKresearch to work on cancer initiation with @SwantonLab @TheCrick! Ever grateful to @drjkrane @AFrankell for the supervision and mentorship

[3/6] Faiz Jabbar will investigate what processes co-operate with somatic mutagenesis in histologically normal tissues to initiate cancer with a focus on non-small cell #LungCancer. @faizjab | @ImperialNHS | #CRUKFunded

Post attachment